{
  "name": "Andrew David Moore",
  "tagline": "Resumé live",
  "body": "### Experience\r\n1/2016-present  \r\n>**Principal, DC Web Consultants LLC, Washington, DC**, [dcwebconsultants.com](http://dcwebconsultants.com)  \r\n>Working with condo associations to customize member notice boards and document stores  \r\n>Strengthening members section of allerg.qc.ca to include forum and ongoing CME activities  \r\n\r\n2000–present  \r\n>**Specialist in Allergy/Immunology, Baltimore/Washington, USA and Brossard, QC, Canada**  \r\n>Facilitated and oversaw creation of physician user templates in electronic-medical records  \r\n>Simplified general tech available to physician colleagues and staff  \r\n\r\n1999-2001  \r\n>**Physician Editor**, Conceptis Technologies (now **WebMD**, [theheart.org](http://theHeart.org)), Montréal, QC, Canada  \r\n>Redesigned medical editing and multimedia template construction for CME web content  \r\n\r\n\r\n### Appointments\r\n2014-present  \r\n>Member, **Canadian Internet Registration Authority**  \r\n\r\n2012-present  \r\n>Member, **Examination Committee Member in Clinical Immunology and Allergy**  \r\nRoyal College of Physicians and Surgeons of Canada  \r\n\r\n2011-present  \r\n>**L’Association des allergologues et immunologues du Québec**   \r\nExecutive member, Webmaster, [allerg.qc.ca](http://allerg.qc.ca)  \r\n\r\n2009-2015  \r\n>**Clinical teaching professor**, Université de Sherbrooke  \r\nDepartment of Pediatrics, Division of Immunology and Allergy\r\n\r\n\r\n###Education\r\n2015-2016  \r\n>Nanodegree in **Full-Stack Web Development**, [Udacity.com](http://udacity.com)  \r\n\r\n2001  \r\n>Seminars in **Presenting Data and Information**, by Edward Tufte  \r\n\r\n1994-1999  \r\n>**Fellowship and Residency**, Internal Medicine, Allergy and Clinical Immunology  \r\nMontreal General Hospital (**McGill University**), Montréal, QC, Canada\r\n\r\n1990-1994  \r\n>**MDCM**, McGill University, Montréal, QC, Canada  \r\n\r\n1986-1990  \r\n>**B.Sc., honors**, Immunology and Mathematics, University of Toronto, Toronto, ON, Canada  \r\n\r\n\r\n###Projects\r\n02/2016  \r\n>**Conference App** (As part of the Full Stack Web Developer Nanodegree program), on [GitHub](https://github.com/erooma/Conference-Application)  \r\n● Improved upon an API server for a conference web (and native Android) application  \r\n● Including: user authentication, profiles, conference information and data queries  \r\nSkills: Google App Engine ● API Endpoints ● Datastore ● Python  \r\n\r\n05/2013  \r\n>**The 26th Scientific Bram Rose Conference**, Québec  \r\n● “La technologie au service de notre pratique quotidienne”  \r\n● Designed and implemented an online survey for members in advance of presentation  \r\nSkills: HTML ● JavaScript ● Public speaking ● PowerPoint  \r\n\r\n2011-present  \r\n>**Website for the Association of Allergists and Immunologists of Québec**, [allerg.qc.ca](http://allerg.qc.ca)  \r\n● Created an online-home for the Association of Allergists and Immunologists of Québec  \r\n● Designed for patients, health-professionals and Allergist members including a native CMS  \r\n● A crucial factor in recertification of our specialty by Québec and Canadian authorities  \r\nSkills: HTML ● CSS ● JavaScript ● PHP  \r\n\r\n1999-2001  \r\n>**Multimedia Online Conferences**, [theheart.org](http://theheart.org)  \r\n● Created and implemented CME online conferences in cardiology and rheumatology  \r\nSkills: HTML ● Photoshop ● PowerPoint ● SoundForge  \r\n\r\n\r\n### Skills\r\n>**Languages** (spoken and written)  \r\nEnglish ● French   \r\n\r\n>**Coding languages and frameworks**  \r\nHTML ● CSS ● JavaScript ● PHP ● Bootstrap ● jQuery ● Python ● Flask  \r\nSQL ● MySQL ● PostgreSQL  \r\n\r\n\r\n\r\n### Research Support – Grants\r\n2009-2014\t\r\n>Co-Applicant, Public Health Agency of Canada (PHAC)  \r\nCanadian Institutes of Health Research (CIHR) Influenza Research Network (PCIRN)  \r\nDr. S. Halperin, Nominated Principal Applicant. \r\n\r\n1998\r\n>Co-Principal Investigator, Incidence of malignancy in patients with SLE  \r\nLupus Québec, Montréal, QC, Canada\r\n\r\n\r\n### Research - Clinical Trials\r\n\r\n2013-2015\t\t\r\n>Principal Investigator, Charles LeMoyne Hospital  \r\nClinical Trials in Sublingual Immunotherapy for the Treatment of Perennial Allergic Rhinitis\r\n\r\n2010-2015\r\n>Principal Investigator, Charles LeMoyne Hospital  \r\nClinical Investigation of Anaphylaxis Following H1N1 Influenza Vaccination\r\n\r\n2001-2005\r\n>Principal Investigator, ENTAA Care, Glen Burnie, MD, USA  \r\nClinical Trials and Safety Studies in:  childhood exercise-induced asthma;  \r\nadult asthma; allergic rhinitis; acute sinusitis and community acquired pneumonia\r\n\r\n\r\n### Professional and Community Service\r\n2012-present\t\t\r\n>Expert Advisory Committee on the Vigilance of Health Products (EAC-VHP)   \r\nCommittee member representing the healthcare professional sector  \r\nHealth Products and Food Branch, Health Canada\r\n\r\n2011-present\r\n>L’Association des allergologues et immunologues du Québec  \r\nWebmaster, [allerg.qc.ca](http://allerg.qc.ca)\t\t\t\r\n\r\n2011-present\r\n>L’Association Québécoise des allergies alimentaires  \r\nScientific advisory board member \r\n \t\r\n2008-2015\r\n>Speaker, Merck Canada  \r\n\r\n2007-2015\r\n>Comité de pharmacologie et de thérapeutique   \r\nMember, Charles LeMoyne Hospital\r\n\r\n2006-2013\r\n>Speaker, Medical consultant, Pfizer Canada (previously, King Pharma)\r\n\r\n2013\r\n>Medical consultant, Sanofi\r\n\r\n2012\r\n>Scientific advisory board member, Viro Pharma\r\n\r\n2007-2009\r\n>Speaker, Medical consultant, Nycomed Canada (previously, Altana)\r\n\r\n2002-2005\r\n>North Arundel Hospital and ENTAA Care, Severna Park, Maryland  \r\n“Camp Airways”, a day-camp for children with asthma\r\n\r\n1999-2001\r\n>Ad Hoc Committee for Systemic Lupus Erythematosus (SLE) Response Criteria  \r\nMember, Working Group of the American College of Rheumatology\r\n\r\n1998-1999\r\n>President, Canadian Allergy and Clinical Immunology Fellows’ Association \r\n\r\n\r\n\r\n### Professional and Community Presentations\r\n2014\t\r\n>Medical grand rounds, Charles LeMoyne Hospital, Greenfield Park, QC  \r\n*Les désensibilisations en allergie* : modus operandi\r\n\t\r\n>Congrès Québécois en santé respiratoire, Montréal, QC  \r\n*Les allergies respiratoires*\r\n\r\n>Association des Patients Immunodéficients du Québec, Québec, QC  \r\n*Comment traiter l’angioédème?*\r\n\t\r\n>L’Association pulmonaire du Québec, Café de la Cinémathèque Québécoise, Montréal, QC  \r\n*La Rhinite Allergique, toujours en saison*\r\n\t\r\n>CSSS Richelieu-Yamaska, Ville de Saint-Hyacinthe, QC  \r\n*Allergies et immunothérapie*\r\n\r\n2013\t\r\n>Association des Patients Immunodéficients du Québec, Longueuil, QC  \r\n*Qu’est-ce que l’angioédème?*\r\n\t\r\n>The 26th Scientific Bram Rose Conference, Québec, QC  \r\n*La technologie au service de notre pratique quotidienne*\r\n\t\r\n2012 \t\r\n>McGill Continuing Health Professional Education  \r\nOnline “Wednesday E-learning series”, *Food and Environmental Allergies*\r\n\r\n2007\t\r\n>Medical grand rounds, Charles LeMoyne Hospital, Greenfield Park, QC  \r\n*Les allergies alimentaires*\r\n\t\r\n2006\r\n>Medical grand rounds, Charles LeMoyne Hospital, Greenfield Park, QC  \r\n*Le nouveau traitement anti-IgE pour les maladies allergiques*\r\n\t\r\n2004\r\n>Medical grand rounds, Kingston General Hospital, Kingston, Ontario  \r\n*Recent Advances in the Management of IgE Mediated Hypersensitivity*\r\n\r\n2003\t\r\n>Pediatric grand rounds, Anne Arundel Medical Center, Annapolis, Maryland  \r\n*Update on Pediatric Asthma*\r\n\r\n1998\r\n>Moore AD, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, St. Pierre Y, Joseph L, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile E, Clarke AE, “Interpersonal support and health status in systemic lupus erythematosus [abstract, presentation]”, Quality Life Res 1998;7:640\r\n\r\n>Moore AD, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, St. Pierre Y, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile JM, Clarke AE, “The use of alternative medical therapies in patients with systemic lupus erythematosus [abstract, presentation]”, Arthritis Rheum 1998;41:S133\t\r\n\r\n1996\r\n>Moore AD, Clarke AE, Danoff DS, Neville C, Fortin PR, “Can utility measures be used in lupus research? A validation and reliability study [abstract, presentation]”, Arthritis Rheum 1996;39:S322 \r\n\r\n\r\n###Abstracts\r\n2005\r\n>Moore AD, Ominsky B, Shochet M, Jacobs SL, “Selective Ig-A deficiency and Mycobacterium kansasii infection [abstract]”, Allergy Asthma Clin Immunol 2005;1:111\r\n\r\n1999\r\n>Moore AD, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, St. Pierre Joseph L, Penrod J, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile JM, Clarke AE, “Alternative medicine reflects care seeking behaviour in SLE [abstract]”,  Arthritis Rheum 1999;42:S327\t\r\n\r\n1998\r\n>Ferland D, Moore AD, Clarke AE, Belisle P, Joseph L, Fortin PR, “Frequency of lupus flares over four years [abstract]”, J Rheumatol 1998;25(S52);74\r\n\r\n>Moore AD, Ferland D, Calrke AE, Belisle P, St. Pierre Y, Joseph L, Penrod J, Fortin PR; “The direct costs of a flare in systemic lupus erythematosus (SLE) [abstract]”, Arthritis Rheum 1998;41:S228\r\n\r\n>Fortin PR, Ferland D, Moore AD, Belisle P, Joseph L, Clarke AE; “Rates and predictors of lupus flares” [abstract]”, Arthritis Rheum 1998;41:S218\r\n\r\n\r\n### Publications\r\n>Rouleau I, De Serres G, Drolet JP, Banerjee D, Lemire C, Moore A, Paradis L, Alizadhefar R, Des Roches A, Chan ES, Stark D, Benoit M, Skowronski DM, On behalf of the PCIRN (Public Health Agency of Canada-Canadian\r\nInstitutes for Health Research Influenza Research) Network.  “Allergic symptoms after pandemic influenza\r\nvaccination rarely mediated by vaccine specific IgE”, J Allergy Clin Immunol 2012;130:1423-1426\r\n\r\n>Ben-Shoshan M, Moore A, Primeau M-N, “Anaphylactic reaction to Clarithromycin in a child”, Allergy 2009;64:962-963\r\n\r\n>Bernatsky S, Joseph L, Bélisle P, Boivin J-F, Rajan R, Moore A, Clarke A. “Bayesian modelling of imperfect ascertainment methods in cancer studies”, Stat Med 2005;24:2365-2379\r\n\r\n>ACR Ad Hoc Committee on SLE Response Criteria. “The American College of Rheumatology response criteria for systemic lupus erythematosus: Measures of overall disease activity”, Arthritis Rheum 2004;50:3418-3426\r\n\r\n>Ad Hoc Working Group on Steroid-Sparing Criteria in Lupus. “Criteria for steroid sparing ability of interventions in systemic lupus erythematosus: Report of a consensus meeting”, Arthritis Rheum 2004;50:3427-3431\r\n\r\n>Bernatsky S, Ramsey-Goldman R, Gordon C, Joseph L, Boivin JF, Rajan R, Allen A, Moore AD, Leung M-H, Clarke A. “Factors associated with abnormal Pap results in systemic lupus erythematosus (SLE)”, Rheumatology 2004;43:1386-1389\r\n\r\n>Bernatsky S, Clarke A, Ramsey-Goldman R, Joseph L, Boivin J-F, Rajan R, Moore AD, Leung M-H, Angela Allen, Gordon C. “Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus”, Rheumatology 2004;43:1178-1181\r\n\r\n>Bernatsky S, Ramsey-Goldman R, Boivin J-F, Joseph L, Moore AD, Rajan R, Clarke A. “Do traditional Gail model risk factors account for increased breast cancer in women with lupus?”, J Rheumatol 2003;30:1505-1507\r\n\r\n>Bernatsky S, Boivin JF, Joseph L, St. Pierre Y, Moore A, Rajan R, Clarke A. “Prevalence of factors influencing cancer risk in women with lupus: Social habits, reproductive issues, and obesity”, J Rheumatol 2002;29:2551-2554\r\n\r\n>Moore AD, Petri MA, Manzi S, Isenberg DA, Gordon C, Senecal JL, St. Pierre Y, Joseph L, Penrod J, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile JM, Clarke AE. “The use of alternative medical therapies in patients with systemic lupus erythematosus (SLE)”, Arthritis Rheum 2000;43:1410-1418\r\n\r\n>Moore AD, Joseph L. “Sample size considerations for superiority trials in systemic lupus erythematosus (SLE)”, Lupus 1999;8:612-619\r\n\r\n>Moore AD, Clarke AE, Danoff DS, Joseph L, Bélisle P, Neville C, Fortin PR. “Can health utility measures be used in lupus research? A comparative validation and reliability study of four utility indices”, J Rheumatol 1999;26:1285-1290",
  "google": "",
  "note": "Don't delete this file! It's used internally to help with page regeneration."
}